Tislelizumab combined with gemcitabine-cisplatin (GP) chemotherapy

Research studies on Tislelizumab combined with gemcitabine-cisplatin (GP) chemotherapy - conditions it treats, mechanisms of action, and clinical outcomes from peer-reviewed literature.